VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.21
+2.51%Margins
Gross margin
96.2%
EBITDA margin
-88.4%
EBIT margin
-92.2%
Net margin
-83.0%
FCF margin
-65.5%
-25.6%
Return on equity
-20.7%
Return on assets
-26.0%
Return on invested capital
0.27x
Asset turnover
-$202.5M
Cash from operations
$3.12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026